Skip to content
Tech News
← Back to articles

Synchron halts second-generation brain implant trial over performance problems

read original more articles
GoKawiil Brief

Synchron has paused enrollment in the multisite clinical trial of its newer, fully wireless Stentrode device after it failed to perform as expected in early participants. The Brooklyn-based brain-computer interface company says it voluntarily stopped enrollment after identifying a performance issue, and is simultaneously restructuring, cutting jobs and reducing its New York presence while expanding a San Diego team.

Why It Matters

GoKawiil's interpretation of the reporting above, not reported fact.

The setback could slow Synchron's bid to compete with Neuralink and other brain-computer interface developers racing to bring wireless, minimally invasive implants to market. The restructuring and new device development suggest the company may be rethinking its engineering approach rather than simply tweaking the current design, though Synchron has not confirmed what specifically went wrong.

Key Takeaways

Source: wired.com — Emily Mullin, 2026-11-12

Published there as: “Synchron Pauses Trials of Its Brain Implant Due to Performance Issues”

Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.
Keep reading
clinical trials 12 briefs → neuralink 11 briefs → brain-computer interface 10 briefs →